Timo Antero Lappalainen

Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The private company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million.

Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland.

The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise.

Suomen Messut Osuuskunta organizes trade and industry fairs, exhibitions, meetings, and congresses. The company was founded on October 19, 1919 and is headquartered in Helsinki, Finland.